Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Udai Banerji Amit Mahipal |
| Publication date | February 27, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |